The primary purpose of these practical guidelines related to Kawasaki disease (KD) is to contribute to prompt diagnosis and appropriate treatment on the basis of different specialists' contributions in the field. A set of 40 recommendations is provided, divided in two parts: the first describes the definition of KD, its epidemiology, etiopathogenetic hints, presentation, clinical course and general management, including treatment of the acute phase, through specific 23 recommendations.Their application is aimed at improving the rate of treatment with intravenous immunoglobulin and the overall potential development of coronary artery abnormalities in KD. Guidelines, however, should not be considered a norm that limits treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or complications.

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase / Marchesi, A; Tarissi de Jacobis, I; Rigante, D; Rimini, A; Malorni, W; Corsello, G; Bossi, G; Buonuomo, S; Cardinale, F; Cortis, E; De Benedetti, F; De Zorzi, A; Duse, M; Del Principe, D; Dellepiane, Rm; D'Isanto, L; El Hachem, M; Esposito, S; Falcini, F; Giordano, U; Maggio, Mc; Mannarino, S; Marseglia, G; Martino, S; Marucci, G; Massaro, R; Pescosolido, C; Pietraforte, D; Pietrogrande, Mc; Salice, P; Secinaro, A; Straface, E; Villani, A.. - In: THE ITALIAN JOURNAL OF PEDIATRICS. - ISSN 1824-7288. - 44:(2018), p. 102. [10.1186/s13052-018-0536-3]

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

Esposito S;
2018

Abstract

The primary purpose of these practical guidelines related to Kawasaki disease (KD) is to contribute to prompt diagnosis and appropriate treatment on the basis of different specialists' contributions in the field. A set of 40 recommendations is provided, divided in two parts: the first describes the definition of KD, its epidemiology, etiopathogenetic hints, presentation, clinical course and general management, including treatment of the acute phase, through specific 23 recommendations.Their application is aimed at improving the rate of treatment with intravenous immunoglobulin and the overall potential development of coronary artery abnormalities in KD. Guidelines, however, should not be considered a norm that limits treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or complications.
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase / Marchesi, A; Tarissi de Jacobis, I; Rigante, D; Rimini, A; Malorni, W; Corsello, G; Bossi, G; Buonuomo, S; Cardinale, F; Cortis, E; De Benedetti, F; De Zorzi, A; Duse, M; Del Principe, D; Dellepiane, Rm; D'Isanto, L; El Hachem, M; Esposito, S; Falcini, F; Giordano, U; Maggio, Mc; Mannarino, S; Marseglia, G; Martino, S; Marucci, G; Massaro, R; Pescosolido, C; Pietraforte, D; Pietrogrande, Mc; Salice, P; Secinaro, A; Straface, E; Villani, A.. - In: THE ITALIAN JOURNAL OF PEDIATRICS. - ISSN 1824-7288. - 44:(2018), p. 102. [10.1186/s13052-018-0536-3]
File in questo prodotto:
File Dimensione Formato  
Kawasaki disease_guidelines of the Italian Society of Pediatrics - part 1.pdf

accesso aperto

Tipologia: Versione (PDF) editoriale
Licenza: Creative commons
Dimensione 742.19 kB
Formato Adobe PDF
742.19 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2864174
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 42
social impact